Ge Healthcare Enters Homecare Segment With Strategic Investment In Pulsenmore, Aims To Increase Peace Of Mind For Expectant Mothers And Reduce In-Person Visits
Ge Healthcare Enters Homecare Segment With Strategic Investment In Pulsenmore, Aims To Increase Peace Of Mind For Expectant Mothers And Reduce In-Person Visits
05/12/22, 1:36 PM
GE Healthcare has entered into an agreement to invest up to $50 million in Israeli start-up Pulsenmore, marking another strategic step forward in enabling precision health. This investment is aimed at accelerating global adoption of Pulsenmore’s homecare ultrasound solutions and will also support their goal to pursue U.S. FDA clearance and commercial expansion. In addition to its equity investment, GE Healthcare will also partner with Pulsenmore to distribute its products in Europe and other markets as the product becomes available for commercial distribution and collaborate closely on developing ultrasound-based healthcare offerings that cater to the burgeoning homecare market, which is expected to reach USD $662.67 billion by 2027 and poised to grow at a compound annual growth rate of 14.2%i.
Company Info
Company
Ge Healthcare
Additional Info
GE Healthcare is the $17 billion* healthcare business of GE (NYSE: GE). As a leading global medical technology, pharmaceutical diagnostics and digital solutions innovator, GE Healthcare enables clinicians to make faster, more informed decisions through intelligent devices, data analytics, applications and services, supported by its Edison intelligence platform. With over 100 years of healthcare industry experience and around 47,000 employees globally, the company operates at the center of an ecosystem working toward precision health, digitizing healthcare, helping drive productivity and improve outcomes for patients, providers, health systems and researchers around the world.
Follow us on Facebook, LinkedIn, Twitter, and Insights for the latest news, or visit our website www.gehealthcare.com for more information.
*Excluding BioPharma.